Seshagiri Rao Nandula

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells”.

Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells

Stem Cell Research & Therapy(2022)10.1186/s13287-022-02775-6

N/A

0.299DataRank · unranked

3 citations

Seshagiri Rao Nandula, Hassan Awal, Gary L. Simon, Sabyasachi Sen, Adrian Elzarki

The parotid secretory protein BPIFA2 is a salivary surfactant that affects LPS action

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.08.940163

N/A

0DataRank · unranked

1 citations

Ian Huxford, Thomas T. Wheeler, Conrado Aparicio, Sven‐Ulrik Gorr, Seshagiri Rao Nandula

Cardiovascular Disease (CVD) Risk Assessment of HIV Medication Regimens using hematopoietic CD34+ progenitor cells

Research Square(2022)10.21203/rs.3.rs-1226890/v1

N/A

0DataRank · unranked

2 citations

Seshagiri Rao Nandula, Hassan Awal, Gary L. Simon, Sabyasachi Sen, Adrian Elzarki